Postextubation airway obstruction in children: Are steroids the key to prevention?The unanticipated need for reintubation in the pediatric intensive care unit (PICU) is associated with significant increases in morbidity, mortality, and cost of care. 1 While patients may require reintubation for a multitude of reasons, postextubation airway obstruction (PEAO) secondary to laryngeal edema is one that may be both predictable and modifiable. 2 Laryngeal edema can occur from pressure or irritation by an endotracheal tube resulting in stridor or obstruction after extubation. 1 While this complication occurs in all PICUs, the incidence is highest in low-and middle-income countries due to the presence of unique risk factors. These risk factors include AUTHOR CONTRIBUTIONS Kaitlin Verdone: Conceptualization (equal); writing original draft (lead); writing review and editing (equal). Christopher M. Watson: Conceptualization (equal); writing review and editing (equal).
Reintubation in the pediatric intensive care unit (PICU) increases
morbidity, mortality, and the overall cost of care. Post-extubation
airway obstruction (PEAO) is a potentially predictable cause of
extubation failure and may be prevented by the use of corticosteroids.
Defining which patients are most at risk for the development of POAE as
well as the optimal dose and timing of corticosteroids for prevention is
critical. We review the current literature regarding the use of
corticosteroids surrounding extubation in the PICU and discuss the
implications that a clear algorithm for identification and treatment of
these patients would have in the care of critically ill children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.